Prostate cancer represents a serious threat to men all over the world, especially those over the age of 65, and is the second leading cause of cancer death among males in both the United States and United Kingdom.
Until recently, the risk level for men living in East Asia was lower than virtually any other region of the world. This is now changing, however, as a result of both lifestyle and demographic factors. “This increased risk is probably due to the shift to a westernized lifestyle, including food, and the rapid increase in the aging population,” explains Hidewaki Nakagawa of the RIKEN Center for Genomic Medicine in Yokohama. Indeed, estimates from the United Nations suggest that the percentage of the population of East Asia that are over the age of 65 will more than double between 2009 and 2050, and Japan in particular is projected to have by far the greatest proportion of elderly citizens.
In addition to these environmental factors, researchers have identified dozens of genetic changes that appear to represent potential risk factors for prostate cancer. All of these were identified based on screens performed on individuals of European ancestry, but a new genomic screen performed by Nakagawa and collaborators from throughout Japan has now identified several novel genetic variants that may prove valuable in diagnosing and treating the growing pool of at-risk Asian men.
Taking it to the bank
Nakagawa’s team has routinely partnered with scientists from BioBank Japan, an initiative launched in 2003 at the University of Tokyo in order to help scientists identify the bases for diverse medical conditions. “This project was started with the goal of collecting samples from a total of 300,000 individuals who have had at least one of 47 diseases, from a collaborative network of 66 hospitals located throughout Japan,” he explains. For this particular study, the researchers obtained DNA from1,583 prostate cancer patients and 3,386 cancer-free control subjects.
Nakagawa and his colleagues used these samples to perform what is known as a genome-wide association study (GWAS). Any given human genome is littered with large numbers of individual nucleotide variations, also known as single-nucleotide polymorphisms (SNPs), which reside both within and in-between genes. From a GWAS, researchers aim to identify SNPs that are significantly more likely to appear in affected individuals than in controls; a SNP with very strong disease association might either represent an actual sequence variation in a relevant gene or provide a useful physical marker for identifying neighboring candidate genes within the same chromosomal region.
The team’s initial analysis of more than half a million different SNPs revealed 37 significantly associated variants at eight different genomic loci, two of which had not been previously linked with prostate cancer. A subsequent replication study, performed with an independent set of 3,001 affected and 5,415 control subjects, enabled the investigators to identify three additional loci, for a total of five novel SNPs. Interestingly, although many of the cancer-associated SNPs that had been previously identified in European populations also exhibited significant linkage among Japanese subjects, more than one-third (12 out of 31) did not. On the other hand, several recent large-scale genomic studies conducted using similar analytical methods but focused primarily on subjects of Northern European ancestry failed to find a significant association for any of the five SNPs identified by Nakagawa and colleagues.
Getting to know the candidates
Beyond the strong evidence supporting their apparent association with disease risk, the majority of these novel SNPs proved to be highly enigmatic. Two of them, rs12653946 and rs9600079, reside within stretches of DNA ranging in length from 20–40,000 bases that contain no known genes. Another two were situated within non-protein-coding regions of a pair of genes; rs13385191 is found in C2orf43, which produces a protein of unknown function, while rs1983891 is located within the gene encoding the so-called ‘forkhead box P4’ (FOXP4) transcription factor. Although it belongs to a family of proteins that have been associated with cell cycle regulation and tumorigenesis, the function of FOXP4 has not yet been characterized.
The final SNP appears to be the most intriguing candidate, as it occurs within a stretch of DNA containing the gene for G protein-coupled receptor C6A (GPRC6A), a protein normally expressed by testosterone-producing Leydig cells. “The GPRC6A gene is likely to be associated with sex hormone production, as shown [by experiments] in knockout mice,” says Nakagawa, “and male hormone levels are one of the most important factors in prostate carcinogenesis.” However, further analysis will be needed to confirm that this is indeed the gene being flagged by rs339331.
Although much work remains to be done in characterizing how the genomic regions identified here contribute to prostate cancer risk, they nevertheless represent important additions to an already large pool of SNPs with potential diagnostic or prognostic value. “This is a much bigger number than exists for other cancers,” says Nakagawa.
Nakagawa also points out that these five SNPs appear to represent loci that could possibly be used for the selective characterization of prostate cancer predisposition within specific ethnic groups, and that these may represent the first set of Asian-specific cancer risk biomarkers. “We are now dedicated to trying to establish a risk estimation system for prostate cancer among Japanese and other Asians by combining many SNPs and other risk factors of prostate cancer,” he says.
About the Researcher
Hidewaki NakagawaHidewaki Nakagawa was born in Osaka, Japan, in 1966. After graduating from the Osaka University School of Medicine in 1991, he embarked on a career in clinical oncology, specifically gastrointestinal and breast cancer, and critical care medicine as a surgeon. He obtained his PhD in 2000 from Osaka University for research on hereditary colorectal cancer. He spent three-and-a-half years as a postdoctoral researcher in cancer genetics with the Human Cancer Genetic Program at Ohio State University, USA, then returned to Japan where he joined the University of Tokyo as an assistant professor in the Institute of Medical Science studying molecular therapeutic targets for prostate and pancreatic cancer. In 2008, he joined the RIKEN Center for Genomic Medicine as team leader of the Laboratory for Biomarker Development. His current research focuses on biomarker development for prostate and gastrointestinal cancer, and cancer genomics based on whole genome sequencing. He is also a participant in the International Cancer Genome Consortium project.
2. Takata, R., Akamatsu, S., Kubo, M., Takahashi, A., Hosono, N., Kawaguchi, T., Tsunoda, T., Inazawa, J., Kamatani, N., Ogawa, O., et al. Genome-wide association study identifies five new susceptivility loci for prostate cancer in the Japanese population. Nature Genetics 42, 751–754 (2010).
Symbiotic bacteria: from hitchhiker to beetle bodyguard
28.04.2017 | Johannes Gutenberg-Universität Mainz
Nose2Brain – Better Therapy for Multiple Sclerosis
28.04.2017 | Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB
More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.
Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...
Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.
"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...
The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.
Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...
The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...
Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.
Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...
28.04.2017 | Event News
20.04.2017 | Event News
18.04.2017 | Event News
28.04.2017 | Medical Engineering
28.04.2017 | Earth Sciences
28.04.2017 | Life Sciences